These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 7880072)

  • 1. Determination of glycated apolipoprotein B in serum by a combination of affinity chromatography and immunonephelometry.
    Panteghini M; Bonora R; Pagani F
    Ann Clin Biochem; 1994 Nov; 31 ( Pt 6)():544-9. PubMed ID: 7880072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of non-enzymatically glycated apolipoprotein A1.
    Caines PS; Thibert RJ; Draisey TF; Foreback CC; Chu JW
    Clin Biochem; 1989 Aug; 22(4):285-7. PubMed ID: 2505947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonenzymic glycation of apolipoprotein B in patients with insulin- and noninsulin-dependent diabetes mellitus.
    Panteghini M; Cimino A; Pagani F; Girelli A
    Clin Biochem; 1995 Dec; 28(6):587-92. PubMed ID: 8595706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-term variations of serum glycated apolipoprotein B.
    Stahl AJ; Rima A; Blickle JF; Brogard JM
    Diabetes Metab; 1998 Apr; 24(2):151-5. PubMed ID: 9592640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A simple method for the measurement of total and glycated apolipoprotein B and its relevance to apolipoprotein-B metabolism in diabetes mellitus.
    Kortlandt W; Benschop C; Erkelens DW; Thijssen JH
    Clin Chim Acta; 1989 Dec; 186(1):109-17. PubMed ID: 2612004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-enzymatic glycation of apolipoprotein B in the sera of diabetic and non-diabetic subjects.
    Tames FJ; Mackness MI; Arrol S; Laing I; Durrington PN
    Atherosclerosis; 1992 Apr; 93(3):237-44. PubMed ID: 1590828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-enzymatic glycation of lipoprotein(a) in vitro and in vivo.
    Doucet C; Huby T; Ruiz J; Chapman MJ; Thillet J
    Atherosclerosis; 1995 Nov; 118(1):135-43. PubMed ID: 8579623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical significance of serum-glycated apolipoprotein B measured by the digestion LDL sediment fraction with protease].
    Shishino K; Ochi M; Murase M; Osawa H; Makino H
    Rinsho Byori; 2006 Jun; 54(6):583-8. PubMed ID: 16872007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-density lipoprotein particle size, triglyceride-rich lipoproteins, and glucose tolerance in non-diabetic men with essential hypertension.
    Rubies-Prat J; Ordóñez-Llanos J; Martin S; Blanco-Vaca F; Molina L; Goday A; Pedro-Botet J
    Clin Exp Hypertens; 2001 Aug; 23(6):489-500. PubMed ID: 11478431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Semiautomated determination of glycated albumin in glycaemic control of diabetic patients.
    Cabre M; Joven J; Simo JM; Matas C; Camps J
    Clin Biochem; 1994 Aug; 27(4):307-9. PubMed ID: 8001294
    [No Abstract]   [Full Text] [Related]  

  • 11. Characterization of the non enzymatic glycation of high density lipoprotein in diabetic patients.
    Calvo C; Ponsin G; Berthezene F
    Diabete Metab; 1988; 14(3):264-9. PubMed ID: 3137109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipoprotein composition in insulin-dependent diabetes mellitus with chronic renal failure: effect of kidney and pancreas transplantation.
    Hughes TA; Gaber AO; Amiri HS; Wang X; Elmer DS; Winsett RP; Hathaway DK; Hughes SM; Ghawji M
    Metabolism; 1994 Mar; 43(3):333-47. PubMed ID: 8139482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Convenient assay for glycated apolipoprotein B using protease].
    Shishino K; Ochi M; Murase M; Osawa H; Makino H
    Rinsho Byori; 2005 Jun; 53(6):504-8. PubMed ID: 16026076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunologic detection and measurement of glycated apolipoprotein B with site specific monoclonal antibodies.
    Shea EA; Cohen MP
    J Immunol Methods; 1993 Jun; 162(1):85-95. PubMed ID: 8509655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of serum glycated lipoprotein(a) levels in noninsulin-dependent diabetic patients.
    Klaya F; Durlach V; Bertin E; Monier F; Monboisse JC; Gillery P
    Clin Biochem; 1997 Apr; 30(3):227-30. PubMed ID: 9167899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycation of LDL in non-diabetic people: Small dense LDL is preferentially glycated both in vivo and in vitro.
    Younis N; Charlton-Menys V; Sharma R; Soran H; Durrington PN
    Atherosclerosis; 2009 Jan; 202(1):162-8. PubMed ID: 18511055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunonephelometric quantitation of the apolipoprotein C-III in human plasma.
    Bury J; De Keersgieter W; Rosseneu M; Belpaire F; Christophe J
    Clin Chim Acta; 1985 Feb; 145(3):249-58. PubMed ID: 3987028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble LDL-immune complexes in type 2 diabetes and vascular disease.
    Turk Z; Sesto M; Skodlar J; Ferencak G; Turk N; Stavljenić-Rukavina A
    Horm Metab Res; 2002 Apr; 34(4):196-201. PubMed ID: 11987029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation, characterization, and metabolism of the glycated and nonglycated subfractions of low-density lipoproteins isolated from type I diabetic patients and nondiabetic subjects.
    Klein RL; Laimins M; Lopes-Virella MF
    Diabetes; 1995 Sep; 44(9):1093-8. PubMed ID: 7657034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycated apolipoprotein B-A surrogate marker of subclinical atherosclerosis.
    Dev K; Sharma SB; Garg S; Aggarwal A; Madhu SV
    Diabetes Metab Syndr; 2016; 10(2):78-81. PubMed ID: 26614298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.